Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05675501 · ClinicalTrials.gov registry record · Phase 1
Evaluation of Topical Encapsulated Benzoyl Peroxide on the Skin Microbiome and Skin Biophysical Properties
A Phase 1 study of Papulopustular Rosacea, sponsored by Sol-Gel Technologies.
- Completed
- Registry status
- Phase 1
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT05675501 is a Phase 1 study of Papulopustular Rosacea that has completed, run by Sol-Gel Technologies. The registered enrollment target is 31 participants, below the 277-participant average among 11 other Papulopustular Rosacea trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05675501, a Phase 1 study of Papulopustular Rosacea, has completed, sponsored by Sol-Gel Technologies.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall objective of this study is to assess how the use of the drug may shift the skin microbiome and skin biophysical properties. Specifically, the study objectives were to assess the following: * How the drug affects the skin microbiome compared with vehicle when applied once daily for 8 weeks in subjects with papulopustular rosacea. * How the drug affects the skin physical properties compared with vehicle when applied once daily for 8 weeks in subjects with papulopustular rosacea.
Conditions Studied
Interventions
- DRUG Encapsulated Benzoyl Peroxide Cream
Study Locations (1)
California
- Integrative Skin Science and Research (ISSR) - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2020-06-10 |
| Est. Completion | 2021-07-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05675501
The ClinicalTrials.gov registry entry for NCT05675501 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 277-participant average among 11 other Papulopustular Rosacea trials with a reported enrollment target (89% lower). The listed sponsor is Sol-Gel Technologies, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Papulopustular Rosacea appearing as the primary indexed condition, and to 1 intervention - of which Encapsulated Benzoyl Peroxide Cream is the first listed.
NCT05675501 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05675501 about?
NCT05675501 is a clinical study titled "Evaluation of Topical Encapsulated Benzoyl Peroxide on the Skin Microbiome and Skin Biophysical Properties". The overall objective of this study is to assess how the use of the drug may shift the skin microbiome and skin biophysical properties. Specifically, the study objectives were to assess the following: * How the drug affects the skin microbiome compared with vehicle when applied once daily for 8 wee...
What is the current status of trial NCT05675501?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 31 participants. The study started on 2020-06-10. Estimated completion is 2021-07-15.
What conditions does trial NCT05675501 study?
This clinical trial studies the following conditions: Papulopustular Rosacea.
What interventions are being tested in trial NCT05675501?
The interventions under investigation include: Encapsulated Benzoyl Peroxide Cream (DRUG).
Who is sponsoring clinical trial NCT05675501?
This trial is sponsored by Sol-Gel Technologies, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05675501 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Papulopustular Rosacea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema
COMPLETED · Phase 1
-
Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform Rosacea
RECRUITING · Phase 2
-
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
COMPLETED · Phase 3
-
Excel V 532 nm KTP Laser for Treatment of Erythematotelangiectatic Rosacea & Papulopustular Rosacea
COMPLETED · NA
-
Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea
COMPLETED · Phase 4
-
A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.